ARCHIVES

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

This article is from The Cancer Letter archive.

Vol. 36 No. 04 | February 5, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Authorization Bills Require NCI To Spend 10% On Cancer control

February 12, 1993

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

Foundation Offers Funding.

July 4, 2003

DCT Board Gives Concept Approval to “National Drug Discovery Groups,” Suggests Four At $1 Million Each

June 11, 1982

Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program

March 11, 1994

CCIRC Report Suggests Ways To Enhance Role Of Surgeons

July 22, 1977